Yves Jongen becomes Chairman of the Board ad interim26 July 2019
Yves Jongen, currently board member of Synergia Medical, succeeds Reinhard Krickl and becomes Chairman ad interim.Learn more
Synergia Medical obtains funding from the European Commission (Horizon 2020)18 July 2019
We are proud to share that our versatile neurostimulation technological platform will enjoy the support of Horizon 2020.Learn more
We are in the Accenture Innovation Awards 2018 Top 2511 October 2018
For the last couple of months the Accenture Innovation Awards (AIA) has brought us on a journey. Hereby we are proud to announce that our recent work has made it to the Top 25 Health innovators in the AIA competition!
Synergia raises €8.1 million in Series A19 February 2018
Novel opto-electronic neurostimulation prototype in testing prior to CE mark submission
Board strengthened with appointments of Reinhard Krickl as Chairman, and Guy Heynen MD and Pierre Detrixhe
Jacques van Rijckevorsel rewarded for his contribution and named Director Emeritus
Synergia Medical welcomes Reinhard Krickl18 October 2017
Reinhard joined the Board of Synergia Medical as non-executive director with a great experience in international neurostimulation industry.Learn more
A growing team!29 September 2017
We are proud to announce our team's growth with our tenth employee! Welcome to her.Learn more
Synergia Medical in Europe's 20 most promising HealthTech comapnies20 June 2017
Synergia Medical was selected to be part of the 20 most promising European HealthTech companies.
Presentation pitch was held in front of lead European MedTech investors in Lausanne, Switzerland.
First patent granted1 June 2017
Our patent "Photovoltaic Electrical Stimulation Device" has been granted by the European Patent Office.Learn more
Welcome to Yves Jongen and Jacques van Rijckevorsel1 June 2017
We are very pleased to announce that Yves Jongen and Jacques van Rijckevorsel have joined Synergia Medical's Board of directors.
New Director joining the Board1 May 2017
Wim Goemaere joins as new Board member, bringing an impressive financial background.Learn more
NEUROPV project green lighted24 April 2017
1,1 million € of non-dillutive capital granted by the Walloon Region for our NEUROPV project.Learn more
Working prototype28 December 2016
The first working prototype is completed and demonstrated to the company's shareholders.Learn more
Business angels join the team1 September 2015
A seed round of 2,5 mio € is closed with private investors.Learn more
ISO 13485 certification1 May 2015
In less than 12 months, DEKRA notified body grants the company quality system with the ISO 13485 certification.Learn more
First round of private investors2 March 2015
The company is happy to announce its first round of private investors composed by 3F'sLearn more
Proof of concept is working1 December 2014
Our first proof of concept using PV cells is gone out of the lab and is working. Congrats to the dev team!
First employees1 September 2014
In september 2014 our first two employees joined the team. Real work can now start!Learn more
Walloon Region to finance two R&D projects1 May 2014
VitalSyn and OptiStart R&D projects are financed by Région Wallonne's DGO6Learn more